News

Participate in LLS COVID-19 Antibody Research Study
22 Mar, 2021
The Leukemia & Lymphoma Society (LLS) is undertaking a unique research study focusing on the antibody response among blood cancer patients in the United States. Participating is easy, and the end result will be a large-scale collection of data from vaccinated blood cancer patients.

The LLS needs your help as “citizen scientists” to contribute to this exciting research initiative. The LLS’s National Patient Registry is currently focused on answering important questions about blood cancer patients and the COVID-19 vaccines.

The research study will monitor antibody production and response resulting from COVID-19 vaccination. This will involve having your blood drawn at a local LabCorp service center. The number of blood tests asked for will depend on when you have, or are scheduled to, receive your vaccine.

If you are interested in joining please visit the LLS Registry Website and click “Join Today” to provide your consent to join this timely research study. After they receive your consent, they will ask a few questions about your COVID-19 vaccination status. The LLS will provide you with a lab request slip and the LabCorp website for you to schedule your appointment at a time and place most convenient for you.

Together, the WM community and the LLS will change the future of blood cancer care.

If you have any questions, please reply via email to [email protected] or call (844)-696-7228.

Share This